Here is a compiled review of material insider securities transactions reported for Thursday, February 5, 2026.
Top purchase
Cavco Industries, Inc. (NASDAQ:CVCO) recorded a meaningful direct purchase when director Steven W. Moster acquired 300 shares of the company’s common stock on February 2 at a price of $456.23 per share, for a total cash outlay of $136,869. The filing indicates the buy occurred while the stock had fallen sharply - an 18% decline over the prior week - and InvestingPro data flagged the shares as possibly in oversold territory. After the acquisition, Moster’s direct ownership stands at 2,976 shares, which includes 290 shares underlying Restricted Stock Units that have been allocated but have not yet vested or been delivered.
The report notes that Moster’s purchase price is close to InvestingPro’s Fair Value assessment for the stock, and that analyst price targets for the company range between $575 and $600. In addition, Cavco’s balance sheet position is described as strong, with more cash than debt and an overall financial health rating labeled as "GOOD".
Top sales
The largest single-dollar insider disposal in the filing package involved Royalty Pharma plc (NASDAQ:RPRX). Executive Vice President and Chief Financial Officer Terrance P. Coyne sold a combined 237,531 Class A Ordinary Shares across transactions executed between February 2 and February 4, 2026, according to Form 4 disclosures with the Securities and Exchange Commission. The aggregate proceeds from those sales totaled $10,360,814, with trade prices spanning from $42.0839 to $43.2928 per share.
The sale details are itemized in the filing: on February 2, two tranches of stock were sold - 102,581 shares at a weighted average price of $42.0839 and an additional 5,843 shares at the same weighted average price; on February 3, two further tranches were sold - 108,759 shares at a weighted average price of $42.8432 and 6,195 shares at a weighted average price of $42.8431; and on February 4, 19,076 shares and 1,087 shares were sold at a weighted average price of $43.2928 each.
In the mortgage and consumer finance-related space, UWM Holdings Corp (NYSE:UWMC) reported sales by ten percent owner SFS Holding Corp. The entity sold 1,265,748 shares of Class A Common Stock on February 3 and 4, 2026, generating roughly $6.49 million in proceeds. Prices for those trades ranged from $4.90 to $5.48 per share. The first tranche on February 3 comprised 632,874 shares at a weighted average price of $5.21, with trade prices during the plan execution ranging between $5.01 and $5.48. Following these transactions, SFS Holding Corp. retained ownership of 6,223,769 shares. The filing notes that UWMC has a market capitalization of $8.22 billion and that its shares fell 9.82% over the past week, according to InvestingPro data.
Energy sector insider activity was reflected in Riley Exploration Permian, Inc. (NASDAQ:REPX), where Bluescape Riley Exploration Holdings LLC and affiliated entities sold 230,334 shares of common stock across February 2 to February 4. Those sales generated $6,571,913 in proceeds and were executed at prices between $28.0654 and $28.5625 per share. At the time of the filing Riley Exploration Permian was trading at $28.67 and appeared undervalued by InvestingPro metrics, with a reported price-to-earnings ratio of 7.05. The individual tranches were: 8,806 shares on February 2 at a weighted average price of $28.0654; 73,528 shares on February 3 at an average price of $28.1772; and 148,900 shares on February 4 at an average price of $28.5625. InvestingPro data cited a dividend yield of 5.58% for REPX and noted that the company has raised its dividend for five consecutive years.
In the online gaming and betting sector, Rush Street Interactive, Inc. (NYSE:RSI) saw Chief Executive Officer Richard Todd Schwartz sell 247,114 shares of Class A Common Stock on February 4, 2026. The weighted average sale price was $17.6134, producing proceeds of $4,352,517. Individual trade prices ranged from $16.99 to $18.36 per share. The Form 4 indicates the sales were executed under a pre-arranged 10b5-1 trading plan. Following completion of these sales, Schwartz’s direct ownership stands at 949,048 shares.
Adaptive Biotechnologies (NASDAQ:ADPT) reported a sale by CEO and Chairman Chad M. Robins of 124,998 shares of common stock on February 2, 2026, as reflected in SEC filings. The weighted average price achieved was $18.44, resulting in proceeds of approximately $2.3 million, with individual prices in the transaction ranging from $18.16 to $18.88. The market capitalization referenced in the filing for Adaptive Biotechnologies is $2.64 billion, and InvestingPro data cited a one-year gain in the company’s stock of 114.91%. The stock is reported to be trading at $17.30, slightly below the CEO’s weighted sale price. After the transaction, Robins directly owns 2,459,245 shares.
Context and investor considerations
Monitoring insider purchases and sales can provide investors with one lens on how executives and directors are positioning themselves relative to their company’s stock. Insiders may sell for a variety of non-fundamental reasons, including portfolio diversification or personal financial needs, while significant insider buying is frequently interpreted as a sign of confidence in the business. Market participants should treat insider disclosures as one data point among many and focus on patterns of activity rather than individual trades when forming investment conclusions.
Key points
- Director Steven W. Moster bought 300 shares of Cavco Industries at $456.23 per share, totaling $136,869, increasing his direct holdings to 2,976 shares.
- Royalty Pharma CFO Terrance P. Coyne sold 237,531 shares between February 2 and February 4 for $10,360,814 in aggregate proceeds, with sale prices ranging $42.0839 to $43.2928.
- Large sales occurred across multiple sectors - mortgage finance (UWMC), energy (REPX), gaming (RSI), and biotech (ADPT) - reflecting widespread insider liquidity events.
Risks and uncertainties
- Interpreting a single insider sale as a negative signal can be misleading because insiders may sell shares for personal planning or diversification; this affects how investors should view sales in all impacted sectors.
- Recent share-price volatility noted in filings - including an 18% one-week drop for CVCO and a 9.82% one-week decline for UWMC - underlines market risk for equity holders in the housing and mortgage-related sectors.
- Data points such as investing-provided valuations and analyst targets are referenced in filings but may diverge from market trading levels; investors should be aware of valuation model limitations, particularly in biotech and energy equities.